United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read General business news Glottis Limited (NSE: GLOTTIS) Q2 FY26 results: Air freight surges while sea freight faces price pressure Glottis’ Q2 FY26 results show sequential growth, strong air freight gains, and deeper client traction. Explore how its multimodal strategy is evolving today. bySrinathNovember 17, 2025